Organogenesis Holdings, Inc. (ORGO)
1.42
+0.06
(+4.41%)
USD |
NASDAQ |
Sep 18, 16:00
1.42
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Enterprise Value : 334.97M for Sept. 17, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 17, 2026 | 334.97M |
| September 16, 2026 | 338.83M |
| September 15, 2026 | 347.83M |
| September 14, 2026 | 352.98M |
| September 11, 2026 | 351.70M |
| September 10, 2026 | 356.84M |
| September 09, 2026 | 361.99M |
| September 08, 2026 | 365.85M |
| September 04, 2026 | 380.00M |
| September 03, 2026 | 371.00M |
| September 02, 2026 | 374.86M |
| September 01, 2026 | 369.71M |
| August 31, 2026 | 381.29M |
| August 28, 2026 | 383.86M |
| August 27, 2026 | 383.86M |
| August 26, 2026 | 385.15M |
| August 25, 2026 | 383.86M |
| August 24, 2026 | 374.86M |
| August 21, 2026 | 391.58M |
| August 20, 2026 | 396.73M |
| August 19, 2026 | 405.74M |
| August 18, 2026 | 390.30M |
| August 17, 2026 | 381.29M |
| August 14, 2026 | 390.30M |
| August 13, 2026 | 386.44M |
| Date | Value |
|---|---|
| August 12, 2026 | 392.87M |
| August 11, 2026 | 403.16M |
| August 10, 2026 | 399.30M |
| August 07, 2026 | 399.30M |
| August 06, 2026 | 470.08M |
| August 05, 2026 | 464.93M |
| August 04, 2026 | 464.93M |
| August 03, 2026 | 461.07M |
| July 31, 2026 | 464.93M |
| July 30, 2026 | 475.22M |
| July 29, 2026 | 484.23M |
| July 28, 2026 | 485.52M |
| July 27, 2026 | 488.09M |
| July 24, 2026 | 467.50M |
| July 23, 2026 | 472.65M |
| July 22, 2026 | 477.80M |
| July 21, 2026 | 504.82M |
| July 20, 2026 | 498.38M |
| July 17, 2026 | 497.10M |
| July 16, 2026 | 503.53M |
| July 15, 2026 | 480.37M |
| July 14, 2026 | 461.07M |
| July 13, 2026 | 452.06M |
| July 10, 2026 | 468.79M |
| July 09, 2026 | 476.51M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| cbdMD, Inc. | 5.655M |
| Guardian Pharmacy Services, Inc. | 2.811B |
| ACADIA Pharmaceuticals, Inc. | 3.842B |
| Agenus, Inc. | 572.34M |
| Alnylam Pharmaceuticals, Inc. | 32.51B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -96.27M |
| Revenue (Quarterly) | 43.76M |
| Total Expenses (Quarterly) | 140.02M |
| EPS Diluted (Quarterly) | -0.772 |
| Gross Profit Margin (Quarterly) | 30.84% |
| Profit Margin (Quarterly) | -220.0% |
| Earnings Yield | -58.78% |
| Normalized Earnings Yield | -54.54 |